Keppra 500 MG/5 ML vial 5ML

Ended Awarded

Contract number
SPE2DX25FARZY
Awardee
Awarding agency
Obligated
$6,327

Award facts

Contract value 100% obligated
$6,326.74 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under the SPE2DB Indefinite Delivery Contract (IDC). The contract, valued at $6,326.74, provides for the delivery of KEPPRA 500 MG/5 ML VIAL 5ML, a pharmaceutical product, to support the medical supply needs of military health facilities. The IDC has a total potential value of $499,999,999 and is valid through November 2026, positioning DMS Pharmaceutical Group as a key supplier in the federal pharmaceutical supply chain. This award is not associated with any set-aside designation.

Quick answers

Who was awarded contract SPE2DX25FARZY?

SPE2DX25FARZY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on January 14, 2025.

How much is contract SPE2DX25FARZY worth?

The government has obligated $6,327 on SPE2DX25FARZY.

Is contract SPE2DX25FARZY an order under another contract?

Yes. SPE2DX25FARZY is a delivery order under SPE2DX15D9764, an indefinite delivery contract.

Was contract SPE2DX25FARZY competed?

The extent of competition for SPE2DX25FARZY was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award